{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:39:06Z","timestamp":1707525546759},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,19]]},"DOI":"10.7759\/cureus.50787","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T17:16:43Z","timestamp":1703006203000},"source":"Crossref","is-referenced-by-count":0,"title":["Advanced Heart Block and Asystole After Regadenoson Infusion: When Cautionary Tales Become Reality"],"prefix":"10.7759","author":[{"given":"Christopher S","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2014.04.008","article-title":"Noninvasive stress testing for coronary artery disease","volume":"32","author":"Miller TD","year":"2014","unstructured":"Miller TD, Askew JW, Anavekar NS. Noninvasive stress testing for coronary artery disease. Cardiol Clin. 2014, 32:387-404. 10.1016\/j.ccl.2014.04.008","journal-title":"Cardiol Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192519","article-title":"ACCF\/ASNC\/ACR\/AHA\/ASE\/SCCT\/SCMR\/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine","volume":"119","author":"Hendel RC","year":"2009","unstructured":"Hendel RC, Berman DS, Di Carli MF, et al.. ACCF\/ASNC\/ACR\/AHA\/ASE\/SCCT\/SCMR\/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation. 2009, 119:e561-87. 10.1161\/CIRCULATIONAHA.109.192519","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2017.01.015","article-title":"Cost-effectiveness of diagnostic evaluation strategies for individuals with stable chest pain syndrome and suspected coronary artery disease","volume":"43","author":"Min JK","year":"2017","unstructured":"Min JK, Gilmore A, Jones EC, et al.. Cost-effectiveness of diagnostic evaluation strategies for individuals with stable chest pain syndrome and suspected coronary artery disease. Clin Imaging. 2017, 43:97-105. 10.1016\/j.clinimag.2017.01.015","journal-title":"Clin Imaging"},{"key":"ref4","article-title":"Nuclear Medicine Stress Test","author":"Gopal S","year":"2023","unstructured":"Gopal S, Murphie C. Nuclear Medicine Stress Test. StatPearls [Internet], Treasure Island (FL); 2023."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-019-00345-5","article-title":"Adenosine and the cardiovascular system","volume":"19","author":"Reiss AB","year":"2019","unstructured":"Reiss AB, Grossfeld D, Kasselman LJ, et al.. Adenosine and the cardiovascular system. Am J Cardiovasc Drugs. 2019, 19:449-64. 10.1007\/s40256-019-00345-5","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1940","article-title":"Regadenoson versus dipyridamole: a comparison of the frequency of adverse events in patients undergoing myocardial perfusion imaging","volume":"37","author":"Amer KA","year":"2017","unstructured":"Amer KA, Hurren JR, Edwin SB, Cohen G. Regadenoson versus dipyridamole: a comparison of the frequency of adverse events in patients undergoing myocardial perfusion imaging. Pharmacotherapy. 2017, 37:657-61. 10.1002\/phar.1940","journal-title":"Pharmacotherapy"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nuclcard.2007.06.114","article-title":"Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial","volume":"14","author":"Iskandrian AE","year":"2007","unstructured":"Iskandrian AE, Bateman TM, Belardinelli L, et al.. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007, 14:645-58. 10.1016\/j.nuclcard.2007.06.114","journal-title":"J Nucl Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2009.04.011","article-title":"Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial","volume":"2","author":"Mahmarian JJ","year":"2009","unstructured":"Mahmarian JJ, Cerqueira MD, Iskandrian AE, et al.. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging. 2009, 2:959-68. 10.1016\/j.jcmg.2009.04.011","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2619-0","article-title":"Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy","volume":"41","author":"Brinkert M","year":"2014","unstructured":"Brinkert M, Reyes E, Walker S, et al.. Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy. Eur J Nucl Med Mol Imaging. 2014, 41:511-21. 10.1007\/s00259-013-2619-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.18.5.565","article-title":"Adenosine, the heart, and coronary circulation","volume":"18","author":"Hori M","year":"1991","unstructured":"Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension. 1991, 18:565-74. 10.1161\/01.hyp.18.5.565","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-018-1218-7","article-title":"Adverse effects associated with regadenoson myocardial perfusion imaging","volume":"25","author":"Andrikopoulou E","year":"2018","unstructured":"Andrikopoulou E, Hage FG. Adverse effects associated with regadenoson myocardial perfusion imaging. J Nucl Cardiol. 2018, 25:1724-31. 10.1007\/s12350-018-1218-7","journal-title":"J Nucl Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.01.017","article-title":"Severe bradycardia and asystole following regadenoson in pharmacological myocardial perfusion imaging","volume":"12","author":"Derbas LA","year":"2019","unstructured":"Derbas LA, Thomas GS, Medina CA, Abdel-Karim AA, Saeed IM, Bateman TM. Severe bradycardia and asystole following regadenoson in pharmacological myocardial perfusion imaging. JACC Cardiovasc Imaging. 2019, 12:1288-90. 10.1016\/j.jcmg.2019.01.017","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-015-0387-x","article-title":"ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers","volume":"23","author":"Henzlova MJ","year":"2016","unstructured":"Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers. J Nucl Cardiol. 2016, 23:606-39. 10.1007\/s12350-015-0387-x","journal-title":"J Nucl Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-017-1081-y","article-title":"Incidence of atrioventricular block with vasodilator stress SPECT: a meta-analysis","volume":"26","author":"Andrikopoulou E","year":"2019","unstructured":"Andrikopoulou E, Morgan CJ, Brice L, Bajaj NS, Doppalapudi H, Iskandrian AE, Hage FG. Incidence of atrioventricular block with vasodilator stress SPECT: a meta-analysis. J Nucl Cardiol. 2019, 26:616-28. 10.1007\/s12350-017-1081-y","journal-title":"J Nucl Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.07.058","article-title":"Advanced heart block and unresponsiveness after regadenoson administration during myocardial SPECT study","volume":"176","author":"Agarwal V","year":"2014","unstructured":"Agarwal V, DePuey EG. Advanced heart block and unresponsiveness after regadenoson administration during myocardial SPECT study. Int J Cardiol. 2014, 176:e49-51. 10.1016\/j.ijcard.2014.07.058","journal-title":"Int J Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-014-9898-0","article-title":"Asystole following regadenoson infusion in stable outpatients","volume":"21","author":"Rosenblatt J","year":"2014","unstructured":"Rosenblatt J, Mooney D, Dunn T, Cohen M. Asystole following regadenoson infusion in stable outpatients. J Nucl Cardiol. 2014, 21:862-8. 10.1007\/s12350-014-9898-0","journal-title":"J Nucl Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185979-advanced-heart-block-and-asystole-after-regadenoson-infusion-when-cautionary-tales-become-reality","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:38Z","timestamp":1707509378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185979-advanced-heart-block-and-asystole-after-regadenoson-infusion-when-cautionary-tales-become-reality"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.50787","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,19]]}}}